Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

IceCure Medical Ltd. (ICCM) had Revenue of $0.72M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$0.72M
Net Income	$-3.59M
Cost of Goods Sold	$0.51M
Gross Profit	$0.22M
Operating Expenses	$4.38M
Operating Income	$-3.66M
Non-Operating Income/Expense	$0.07M
Pre-Tax Income	$-3.59M
Normalized Pre-Tax Income	$-3.59M
Income after Taxes	$-3.59M
Income from Continuous Operations	$-3.59M
Consolidated Net Income/Loss	$-3.59M
Normalized Income after Taxes	$-3.59M
EBIT	$-3.66M
EBITDA	$-3.57M
Weighted-Average Shares Outstanding (Basic)	57.64M
Weighted-Average Shares Outstanding (Diluted)	57.64M
Earnings per Share (EPS) (Basic)	$-0.06
Earnings per Share (EPS) (Diluted)	$-0.06
Balance Sheet Financials
Current Assets	$9.44M
Property, Plant, and Equipment	$1.17M
Long-Term Assets	$1.66M
Total Assets	$11.10M
Current Liabilities	$5.00M
Long-Term Debt	$0.11M
Long-Term Liabilities	$0.11M
Total Liabilities	$5.10M
Common Equity	$6.00M
Tangible Shareholders Equity	$6.00M
Shareholders Equity	$6.00M
Common Shares Outstanding	58.62M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-4.04M
Cash Flow from Investing Activities	$-0.01M
Cash Flow from Financial Activities	$2.56M
Beginning Cash	$7.56M
End Cash	$6.04M
Increase/Decrease in Cash	$-1.52M
Stock-Based Compensation	$0.12M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.89
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.02
Debt to Equity Ratio	0.06
Gross Margin	30.07%
Operating Margin	-504.41%
EBIT Margin	-504.41%
EBITDA Margin	--
Pre-Tax Profit Margin	-494.90%
Profit Margin	-494.90%
Free Cash Flow	$-4.04M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.25
Receiveable Turnover	2.42
Days Sales in Receivables	37.24
Return on Equity	-59.80%
Return on Tangible Equity	-59.80%
Return on Assets	-32.31%
Return on Investments	-58.74%
Book Value Per Share	$0.10
Free Cash Flow per Share	$-0.07
Operating Cash Flow per Share	$-0.07

Data from Zacks Investment Research, Inc.